InvestorsHub Logo
Followers 140
Posts 4743
Boards Moderated 2
Alias Born 02/19/2013

Re: Atlanta1 post# 3803

Thursday, 01/28/2016 5:04:25 PM

Thursday, January 28, 2016 5:04:25 PM

Post# of 41350
Believe it or not I actually know a thing or two about biomaterials.

It is exceedingly rare to have new (permanent bone) biomaterials introduced into the market.. far rarer than blizzards in the Northeast US (last two by my count being last week and 1996). My professor was very clear about this in biomaterials class... we only had to memorize a short list of them since the barrier to entry is astoundingly high. By acquiring FDA approval with the Silicone Nitride, AMDA is worth far more than current prices would lead one to believe. Hard to imagine less than $50M just for approval.

Simple, conservative calculations regarding the disruptive, superior material make me think exceptional gains are possible here for anyone willing to hold long term.

I've been toying around with various price targets for 2017-2018 which very conservatively came in at $90/share lowest.

AMDA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News